Fragmin
NDC Package 62856-101-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Fragmin is dalteparin is used to treat and prevent harmful blood clots. Marketed by Eisai Inc., this product is identified by NDC 62856-101 and is authorized under FDA application NDA020287.

Identification & Billing

NDC Package Code
62856-101-10
Package Description
10 SYRINGE in 1 CARTON / 1 mL in 1 SYRINGE (62856-101-01)
Product Code
62856-101
11-Digit Billing Format
62856010110
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Fragmin
Dosage Form
-
Usage Information
Dalteparin is used to treat and prevent harmful blood clots. Preventing harmful blood clots helps to reduce the risk of a stroke or heart attack. This medication helps keep your blood flowing smoothly by lowering the activity of clotting proteins in the blood. Dalteparin is a type of heparin, and works as an anticoagulant (commonly called a "blood thinner"). Conditions that increase your risk of developing blood clots include certain types of surgeries (such as hip replacement or abdominal surgery), long periods of being in one position (immobile), certain types of heart attack, and a certain type of chest pain called unstable angina. For some medical conditions, dalteparin may be used in combination with other "blood thinners." Dalteparin may also be used to treat and prevent clots from coming back in patients with cancer.

Regulatory & Marketing

Labeler Name
Eisai Inc.
FDA Application #
NDA020287
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-22-1994
End Marketing Date
09-30-2016
Listing Expiration
09-30-2016
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62856-101-10 identifies a specific commercial package of 10 syringe in 1 carton / 1 ml in 1 syringe (62856-101-01) of Fragmin, labeled by Eisai Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Eisai Inc. on December 22, 1994. The current certification is valid through September 30, 2016.

What are the primary indications for this medication?

Dalteparin is used to treat and prevent harmful blood clots. Preventing harmful blood clots helps to reduce the risk of a stroke or heart attack. This medication helps keep your blood flowing smoothly by lowering the activity of clotting proteins in the blood. Dalteparin is a type of heparin, and works as an anticoagulant (commonly called a "blood thinner"). Conditions that increase your risk of developing blood clots include certain types of surgeries (such as hip replacement or abdominal surgery), long periods of being in one position (immobile), certain types of heart attack, and a certain type of chest pain called unstable angina. For some medical conditions, dalteparin may be used in combination with other "blood thinners." Dalteparin may also be used to treat and prevent clots from coming back in patients with cancer.

How is this Eisai Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62856010110. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62856-101-10
11-Digit CMS (5-4-2)
62856-0101-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.